FIRST TRUST ADVISORS LP - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 216 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$3,127,451
+48.5%
238,010
+42.4%
0.00%
+100.0%
Q2 2023$2,105,749
+105.2%
167,123
+112.5%
0.00%
+100.0%
Q1 2023$1,026,303
-54.3%
78,644
-38.2%
0.00%
-66.7%
Q4 2022$2,243,490
-44.3%
127,182
-51.9%
0.00%
-40.0%
Q3 2022$4,031,000
+53.4%
264,655
+49.4%
0.01%
+66.7%
Q2 2022$2,628,000
-50.9%
177,175
-25.5%
0.00%
-40.0%
Q1 2022$5,357,000
+109.1%
237,902
+71.3%
0.01%
+150.0%
Q4 2021$2,562,000
-40.0%
138,866
-56.5%
0.00%
-60.0%
Q3 2021$4,272,000
-27.6%
319,472
+0.3%
0.01%
-16.7%
Q2 2021$5,897,000
+351.2%
318,554
+266.1%
0.01%
+200.0%
Q1 2021$1,307,000
-14.5%
87,023
-17.8%
0.00%0.0%
Q4 2020$1,528,000
+421.5%
105,843
+194.3%
0.00%
Q3 2020$293,000
-15.8%
35,969
+13.3%
0.00%
-100.0%
Q3 2019$348,000
-40.4%
31,737
-36.8%
0.00%0.0%
Q2 2019$584,000
-22.5%
50,223
-36.4%
0.00%0.0%
Q1 2019$754,000
+108.3%
79,028
+110.5%
0.00%0.0%
Q4 2018$362,000
-82.2%
37,536
-73.8%
0.00%
-75.0%
Q3 2018$2,038,000
+172.5%
143,024
+129.5%
0.00%
+100.0%
Q2 2018$748,000
-98.9%
62,326
-98.6%
0.00%
-98.8%
Q3 2017$65,557,000
-12.2%
4,606,933
-21.2%
0.17%
-15.1%
Q2 2017$74,628,000
+0.5%
5,848,584
-0.1%
0.20%
-3.4%
Q1 2017$74,253,000
+83.7%
5,855,944
+48.0%
0.21%
+71.7%
Q4 2016$40,411,000
-20.7%
3,957,937
+2.3%
0.12%
-21.1%
Q3 2016$50,935,000
+5.0%
3,867,504
+1.3%
0.15%
-0.7%
Q2 2016$48,488,000
-30.3%
3,817,928
-27.5%
0.15%
-31.7%
Q1 2016$69,580,000
-33.6%
5,267,243
-22.7%
0.22%
-17.6%
Q4 2015$104,737,000
+162.4%
6,809,932
+111.5%
0.27%
+134.5%
Q3 2015$39,918,000
+18.5%
3,219,160
+30.7%
0.12%
+33.3%
Q2 2015$33,699,000
+21.7%
2,463,344
+6.4%
0.09%
+7.4%
Q1 2015$27,701,000
+4.7%
2,316,117
+11.8%
0.08%
-9.0%
Q4 2014$26,461,000
+34.5%
2,072,109
+41.3%
0.09%
+15.6%
Q3 2014$19,674,000
-30.3%
1,466,555
-16.7%
0.08%
-34.2%
Q2 2014$28,243,000
-22.0%
1,759,708
-12.4%
0.12%
-26.4%
Q1 2014$36,220,000
+26.1%
2,008,886
+8.1%
0.16%
+14.4%
Q4 2013$28,722,000
+21.7%
1,857,831
+17.0%
0.14%
+8.6%
Q3 2013$23,604,000
+35.8%
1,587,344
+18.2%
0.13%
+13.3%
Q2 2013$17,377,0001,342,8620.11%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q3 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders